Personal Genome Diagnostics Revenue and Competitors
Estimated Revenue & Valuation
- Personal Genome Diagnostics's estimated annual revenue is currently $16.1M per year.
- Personal Genome Diagnostics's estimated revenue per employee is $155,000
- Personal Genome Diagnostics's total funding is $244.7M.
Employee Data
- Personal Genome Diagnostics has 104 Employees.
- Personal Genome Diagnostics grew their employee count by 13% last year.
Personal Genome Diagnostics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Regulatory and Quality | Reveal Email/Phone |
2 | VP, Technology Innovation | Reveal Email/Phone |
3 | Director Software Quality | Reveal Email/Phone |
4 | Director, Translational Science and Strategy | Reveal Email/Phone |
5 | Director, Bioinformatics | Reveal Email/Phone |
6 | Team Manager | Reveal Email/Phone |
7 | Senior Scientist | Reveal Email/Phone |
8 | Staff Scientist | Reveal Email/Phone |
9 | System Engineer, Bioinformatics | Reveal Email/Phone |
10 | Scientist | Reveal Email/Phone |
Personal Genome Diagnostics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is Personal Genome Diagnostics?
Personal Genome Diagnostics (PGDx) is empowering the fight against cancer by unlocking actionable information from the genome. We are committed to developing a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide. Our expertise in advanced cancer genome analysis ranges from sample preparation and sequencing to data interpretation and analysis. We specialize in high-throughput next-generation sequencing, proprietary algorithms to identify alterations in complex cancer genomes and have developed novel technologies for non-invasive approaches in cancer. PGDx was founded in 2010 by Luis Diaz and Victor Velculescu to help bring novel diagnostic approaches to patients with cancer. They are internationally recognized leaders in cancer genomics who have extensive experience in the application of innovative genomic technologies for drug development and clinical practice.
keywords:N/A
$244.7M
Total Funding
104
Number of Employees
$16.1M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Personal Genome Diagnostics News
MedGenome OncoDNA. Genomic Health Trovagene Fluxion Biosciences Biodesix Epic Sciences Shuwen Biotech Personal Genome Diagnostics Predicine
Personal Genome Services Market Focus on End User, Application, Solution, Component, and Range: 23andMe, Inc, Personal Genome Diagnostics...
Cancer Immuno-Oncology Diagnostics Recent Developments ... Panagene; Perkin Elmer; Personal Genome Diagnostics; Personalis; Precipio...
BALTIMORE, Md.--(BUSINESS WIRE)--Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced the close of a $103 million Series C financing. The financing was led by Cowen Healthcare Investments and joined by new and existing investors including Northpond Ventures, Vens ...
Personal Genome Diagnostics, the venture-backed developer of a novel diagnostic kit for genomic profiling of different cancers in lab settings, has received clearance from the U.S. Food and Drug Administration for its PGDx elio tissue complete test. The test’s approval is another step forward f ...
Other Companies in Baltimore
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18.7M | 104 | -5% | N/A |
#2 | $22.1M | 105 | 6% | N/A |
#3 | $15M | 105 | -7% | N/A |
#4 | $26M | 106 | 47% | N/A |
#5 | $21.7M | 106 | 9% | N/A |